HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Wenhua Li Selected Research

tetrandrine

5/2015Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
4/2015Tetrandrine induces autophagy and differentiation by activating ROS and Notch1 signaling in leukemia cells.
1/2015Tetrandrine induces G1/S cell cycle arrest through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis in vivo.
10/2012Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma.
9/2011Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Wenhua Li Research Topics

Disease

21Neoplasms (Cancer)
09/2015 - 03/2007
5Neoplasm Metastasis (Metastasis)
09/2015 - 06/2010
5Hepatocellular Carcinoma (Hepatoma)
05/2015 - 09/2011
4Infection
08/2015 - 01/2015
4Colorectal Neoplasms (Colorectal Cancer)
03/2015 - 06/2010
4Liver Neoplasms (Liver Cancer)
01/2015 - 09/2011
2Hemolysis
08/2015 - 05/2015
2Wounds and Injuries (Trauma)
01/2015 - 02/2003
2Prostatic Neoplasms (Prostate Cancer)
12/2007 - 03/2007
2Polyps
09/2006 - 04/2002
2Edema
09/2006 - 04/2002
1Leukemia
04/2015
1Acute Promyelocytic Leukemia
04/2015
1Hypersensitivity (Allergy)
03/2015
1Drug Toxicity (Drug Safety)
03/2015
1Stomach Neoplasms (Stomach Cancer)
02/2015
1Neutropenia
06/2014
1Unstable Angina
02/2014
1Myocardial Ischemia (Ischemic Heart Diseases)
02/2014
1Pathologic Constriction (Stenosis)
02/2014
1Ischemia
02/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
02/2014
1Diarrhea
01/2014
1Human Influenza (Influenza)
11/2013
1Myocardial Infarction
06/2013
1Macular Degeneration (Age-Related Maculopathy)
05/2013
1Cataract (Cataracts)
05/2013
1Blindness (Hysterical Blindness)
05/2013
1Carcinoma (Carcinomatosis)
04/2013
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2013
1Thrombocytopenia (Thrombopenia)
01/2013
1Anemia
01/2013
1Fatigue
01/2013
1Stomatitis
01/2013
1Constipation
01/2013
1Proteinuria
01/2013
1Colonic Neoplasms (Colon Cancer)
08/2012

Drug/Important Bio-Agent (IBA)

5tetrandrineIBA
05/2015 - 09/2011
5Reactive Oxygen Species (Oxygen Radicals)IBA
09/2014 - 09/2011
4Phosphotransferases (Kinase)IBA
02/2015 - 10/2012
3bisbenzylisoquinolineIBA
01/2015 - 09/2011
3Fluorouracil (Carac)FDA LinkGeneric
01/2014 - 04/2013
3oxaliplatin (Eloxatin)FDA LinkGeneric
01/2014 - 04/2013
3Leucovorin (Folinic Acid)FDA Link
01/2014 - 04/2013
3Messenger RNA (mRNA)IBA
06/2010 - 01/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008 - 03/2007
3Extracellular Matrix ProteinsIBA
02/2003 - 01/2002
2MicroRNAs (MicroRNA)IBA
09/2015 - 01/2015
2shikoninIBA
09/2014 - 12/2011
2capecitabine (Xeloda)FDA Link
01/2014 - 01/2014
2XELOXIBA
01/2014 - 01/2014
2irinotecan (Camptosar)FDA LinkGeneric
01/2014 - 01/2014
2CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
01/2008 - 03/2007
2Collagenases (Collagenase)FDA Link
04/2002 - 01/2002
2ProcollagenIBA
04/2002 - 01/2002
2Fibronectins (Fibronectin)IBA
04/2002 - 01/2002
2Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
04/2002 - 01/2002
2DecorinIBA
04/2002 - 01/2002
2fibromodulinIBA
04/2002 - 01/2002
2Hyaluronic Acid (Hyaluronan)IBA
04/2002 - 01/2002
1LuciferasesIBA
09/2015
1PhloretinIBA
08/2015
1Carbon MonoxideIBA
08/2015
1sphingosine kinaseIBA
05/2015
13-methyladenineIBA
05/2015
1fisetinIBA
05/2015
1Chloroquine (Aralen)FDA LinkGeneric
05/2015
1Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2015
1EndostatinsIBA
03/2015
1tyrosine receptor (receptor, tyrosine)IBA
02/2015
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
02/2015
1GTP Phosphohydrolases (GTPases)IBA
01/2015
1cetrimonium (hexadecyltrimethylammonium bromide)IBA
01/2015
1ABT 263IBA
07/2014
1sorafenib (BAY 43-9006)FDA Link
07/2014
1Paclitaxel (Taxol)FDA LinkGeneric
06/2014
1Scorpion Venoms (Scorpion Venom)IBA
04/2014
1Protease Inhibitors (Protease Inhibitor)IBA
04/2014
1ChymotrypsinFDA Link
04/2014
1Cyclin D1IBA
04/2014
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
04/2014
1pro-brain natriuretic peptide (1-76)IBA
02/2014
1Brain Natriuretic Peptide (Natrecor)FDA Link
02/2014
15-fluoropyrimidineIBA
01/2014
1Adenosine Monophosphate (AMP)IBA
11/2013
1DobutamineFDA LinkGeneric
06/2013
1zeaxanthinIBA
05/2013
1LuteinIBA
05/2013
1ridaforolimusIBA
01/2013
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2013
1occludinIBA
01/2013
1VimentinIBA
01/2013
1Cadherins (E-Cadherin)IBA
01/2013
1p38 Mitogen-Activated Protein KinasesIBA
08/2012
1N- (2- aminophenyl)- 4- (N- (pyridin- 3- ylmethoxycarbonyl)aminomethyl)benzamide (MS 275)IBA
08/2012

Therapy/Procedure

4Drug Therapy (Chemotherapy)
03/2015 - 04/2013
4Heterologous Transplantation (Xenotransplantation)
01/2015 - 12/2007
1Therapeutics
05/2015
1Intravenous Infusions
03/2015
1Intravenous Injections
01/2015